Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 31, 1998
Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbitsJ L Scism, K M Powers, A A Artru, et al.
Clinical Pharmacology and Therapeutics|December 30, 2011
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeK R Crews, A Gaedigk, H M Dunnenberger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2009
Clonidine pharmacokinetics in pregnancyM L Buchanan, T R Easterling, D B Carr, et al.
American Journal of Hypertension|August 1, 1992
Improvement in metabolic risk factors for coronary heart disease associated with cilazapril treatmentS M Shieh, W H Sheu, D D Shen, et al.
Clinical Pharmacology and Therapeutics|October 18, 2012
Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus dispositionS Zheng, Y Tasnif, M F Hebert, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
First-pass midazolam metabolism catalyzed by 1alpha,25-dihydroxy vitamin D3-modified Caco-2 cell monolayersJ M Fisher, S A Wrighton, P B Watkins, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
First-pass metabolism of midazolam by the human intestineM F Paine, D D Shen, K L Kunze, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patientsK E Thummel, D D Shen, T D Podoll, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantationK E Thummel, D D Shen, T D Podoll, et al.
Pharmacogenetics|December 12, 2001
In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentrationY S Lin, G F Lockwood, M A Graham, et al.
Pageof 11